Search research articles
Contact Us
Filters
Showing results (151-160 of 206) with videos related to
Page
of 21
Sort By:
Journal of Proteome Research
|
September 3, 2013
Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide
Koji Ueda, Ayako Tatsuguchi, Naomi Saichi, et al.
Cancer Genetics
|
June 12, 2022
A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome
Takeshi Sano, Tomohiro Fukui, Noriyuki Makita, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 12, 2017
[Simultaneous Hepatorenal Transplantation from a Brain-Dead Donor for Graft Dysfunction and Renal Insufficiency in a Liver Transplant Recipient : A Case Report]
Hideaki Takada, Takashi Kobayashi, Kohei Ogawa, et al.
Anticancer Research
|
April 25, 2023
Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma
Takeshi Sano, Rihito Aizawa, Katsuhiro Ito, et al.
Japanese Journal of Clinical Oncology
|
October 6, 2025
Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study)
Naoki Terada, Keiji Nihei, Rihito Aizawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 8, 2026
Total Positive Margin Length as a Novel Prognostic Indicator After Radical Prostatectomy
Takafumi Hibino, Masashi Kato, Toyonori Tsuzuki, et al.
Scientific Reports
|
October 24, 2019
eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA
Kei Mizuno, Shusuke Akamatsu, Takayuki Sumiyoshi, et al.
Epigenomics
|
January 29, 2025
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines
Maryam Latarani, Perla Pucci, Mark Eccleston, et al.
Cancer Science
|
May 7, 2021
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13
Kosuke Okasho, Kei Mizuno, Tomohiro Fukui, et al.
Human Molecular Genetics
|
June 28, 2022
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls
Yuya Sekine, Yusuke Iwasaki, Tomomi Aoi, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 206) with videos related to
Sort By:
Page
of 21
Journal of Proteome Research
|
September 3, 2013
Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide
Koji Ueda, Ayako Tatsuguchi, Naomi Saichi, et al.
Cancer Genetics
|
June 12, 2022
A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome
Takeshi Sano, Tomohiro Fukui, Noriyuki Makita, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 12, 2017
[Simultaneous Hepatorenal Transplantation from a Brain-Dead Donor for Graft Dysfunction and Renal Insufficiency in a Liver Transplant Recipient : A Case Report]
Hideaki Takada, Takashi Kobayashi, Kohei Ogawa, et al.
Anticancer Research
|
April 25, 2023
Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma
Takeshi Sano, Rihito Aizawa, Katsuhiro Ito, et al.
Japanese Journal of Clinical Oncology
|
October 6, 2025
Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study)
Naoki Terada, Keiji Nihei, Rihito Aizawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 8, 2026
Total Positive Margin Length as a Novel Prognostic Indicator After Radical Prostatectomy
Takafumi Hibino, Masashi Kato, Toyonori Tsuzuki, et al.
Scientific Reports
|
October 24, 2019
eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA
Kei Mizuno, Shusuke Akamatsu, Takayuki Sumiyoshi, et al.
Epigenomics
|
January 29, 2025
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines
Maryam Latarani, Perla Pucci, Mark Eccleston, et al.
Cancer Science
|
May 7, 2021
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13
Kosuke Okasho, Kei Mizuno, Tomohiro Fukui, et al.
Human Molecular Genetics
|
June 28, 2022
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls
Yuya Sekine, Yusuke Iwasaki, Tomomi Aoi, et al.
Page
of 21